Anti-p62 C-terminal pAb and 1 more item

MBL International Corporation received a contract award from the University of Virginia on August 8, 2026, for the procurement of laboratory reagents and associated fulfillment services. The prime contractor is obligated to deliver 714 vials of anti-p62 C-terminal polyclonal antibody to the contracting organization's designated buyer location. The contract encompasses two primary line items: the supply of anti-p62 C-terminal pAb reagent at a unit price of $1.00 per vial and shipping and handling services charged at $1.00 per occurrence.

The cumulative contract value totals $714.00. The award is documented under Virginia contract identification number A207_PO-0230045-V3. No specific period of performance dates or annual value threshold was provided in the contract documentation. The procurement was executed by the University of Virginia, a state educational institution located in Virginia, though the specific county and ultimate place of performance were not designated in the available contract award information.